Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like Neuralink Announces First-in-Human Clinical Trial of BCI Device May 26, 2023 Armed With New Patent, Indivior Sues Suboxone Generics Applicants February 12, 2018 EMA Sees 28 Percent Increase in Orphan Drug Applications in 2016 February 10, 2017